Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Thienopyridyl compounds that inhibit vanilloid receptor subtype 1 (VR1) and uses thereof

Thienopyridyl compounds that inhibit vanilloid receptor subtype 1 (VR1) and uses thereof

US Patent 8501769 · Granted Aug 6, 2013

Estimated economic value: $106,821,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Diagnosis and treatment of psoriatic arthritis2023
Diagnosis and treatment of psoriatic arthritis2022
Glass treatment apparatus and methods of treating glass2020
Substituted isoxazolopyridazinones and isothiazolopyridazinones and methods of u2020
Tricyclic modulators of TNF signaling2019
Substituted pyrazolopyrimidines and method of use2018
Anti-viral compounds2018
Anti-viral compounds2018
Indole and indoline derivatives and methods of use thereof2018
6-heteroaryloxy- or 6-aryloxy-quinoline-2-carboxamides and method of use2018
Substituted pyrazolopyrimidines and method of use2017
(Indazol-4-yl) hexahydropyrrolopyrrolones and methods of use2017